Publication
Efavirenz concentrations in HIV-infected patients with and without viral hepatitis
dc.contributor.author | Pereira, S | |
dc.contributor.author | Caixas, U | |
dc.contributor.author | Branco, T | |
dc.contributor.author | Germano, I | |
dc.contributor.author | Lampreia, F | |
dc.contributor.author | Papoila, A | |
dc.contributor.author | Monteiro, E | |
dc.date.accessioned | 2012-08-28T15:10:05Z | |
dc.date.available | 2012-08-28T15:10:05Z | |
dc.date.issued | 2008 | |
dc.description.abstract | AIMS: Data on efavirenz in HIV/viral hepatitis co-infected patients is non-consensual, probably due to liver function heterogeneity in the patients included. METHODS: A case control study was performed on 27 HIV-infected patients, with controlled and homogenous markers of hepatic function, either mono-infected or co-infected with HBV/HCV, to ascertain the influence of viral hepatitis on efavirenz concentrations over a 2-year follow-up period. RESULTS: No differences were found in efavirenz concentrations between groups both during and at the end of the follow-up period: control (2.43 +/- 1.91 mg l(-1)) vs. co-infected individuals (2.37 +/- 0.37 mg l(-1)). CONCLUSION: It was concluded that HBV/HCV infections in themselves do not predispose to an overexposure to efavirenz. | por |
dc.identifier.citation | Br J Clin Pharmacol. 2008 Oct;66(4):551-5 | por |
dc.identifier.issn | 0306-5251 | |
dc.identifier.uri | http://hdl.handle.net/10400.10/672 | |
dc.language.iso | eng | por |
dc.peerreviewed | yes | por |
dc.publisher | Wiley-Blackwell | por |
dc.subject | Infecção por HIV | por |
dc.subject | Hepatite B | por |
dc.subject | Hepatite C | por |
dc.subject | HIV infections | por |
dc.subject | Hepatitis B | por |
dc.subject | Hepatitis C | por |
dc.subject | Efavirenz | por |
dc.title | Efavirenz concentrations in HIV-infected patients with and without viral hepatitis | por |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.conferencePlace | London | por |
oaire.citation.endPage | 555 | por |
oaire.citation.startPage | 551 | por |
oaire.citation.title | British Journal of Clinical Pharmacology | por |
oaire.citation.volume | 66 | por |
rcaap.rights | openAccess | por |
rcaap.type | article | por |